[1]
N. Helal, N. et al. 2023. The Role of Oxybutynin Chloride in the Management of Patientswith Benign Prostatic Hyperplasia. Tikrit Journal of Pharmaceutical Sciences. 4, 1 (Apr. 2023), 63–68. DOI:https://doi.org/10.25130/tjphs.2008.4.8.63.68.